Frebini Energy Drink: High-Calorie Nutrition for Children

Frebini Energy Drink delivers 1.5 kcal/ml in a ready-to-use format for children aged 1-12 facing malnutrition risks, providing 300 kcal per bottle from Fresenius Kabi.

Fresenius Kabis Frebini Energy Drink stands out as a specialized high-calorie oral nutritional supplement designed specifically for children. This ready-to-drink formula addresses malnutrition in kids aged 1 to 12 years, whether existing or at risk, making it a key tool in pediatric dietary management.

Updated: 05/14/2026

By Elena Martinez, Senior Product Editor - covering medical nutrition and global health markets.

At a Glance

• Product: Frebini Energy Drink
• Category: High-calorie oral nutrition
• Brand/Manufacturer: Fresenius Kabi
• Primary Use Cases: Malnutrition management in children 1-12 years
• Availability: Ready-to-drink bottles
• Key Markets: Pediatric care worldwide

What Frebini Energy Drink Is and How It Works

Frebini Energy Drink is a nutritionally complete, high-energy oral supplement tailored for young children. Each bottle contains 1.5 kcal per milliliter, delivering 300 kcal total, which supports rapid caloric intake without requiring preparation. The formula includes balanced macronutrients, vitamins, and minerals essential for growth and recovery in malnourished kids.

The product works by providing dense nutrition in a palatable drink form, encouraging compliance among children who may refuse solid foods. It is used under medical supervision as part of a diet plan for conditions like chronic illness, poor appetite, or growth faltering. Healthcare providers recommend it for both inpatient and home settings, with dosages adjusted based on individual needs.

Its composition features high-quality proteins, fats, and carbohydrates, plus fiber in some variants, to promote gut health and sustained energy. This makes Frebini Energy Drink a versatile option in enteral nutrition protocols.

Why Frebini Energy Drink Matters for Consumers and Industry

For parents and caregivers, Frebini Energy Drink offers peace of mind through targeted support for childrens nutritional gaps. In regions with high malnutrition rates, it helps prevent long-term developmental issues, improving quality of life. Pediatricians value its evidence-based formulation, backed by clinical guidelines for oral supplementation.

In the medical nutrition industry, products like Frebini highlight the shift toward age-specific solutions. Fresenius Kabi, a leader in enteral feeding, uses this drink to address pediatric challenges where standard adult formulas fall short. It underscores the growing demand for convenient, high-calorie options amid rising childhood obesity and undernutrition paradoxes globally.

Accessibility via pharmacies and medical suppliers ensures broad reach, particularly in Europe and expanding markets, aiding healthcare systems in cost-effective interventions.

Frebini Energy Drink in the Global Market

Global demand for pediatric nutritional drinks like Frebini Energy Drink rises with awareness of early malnutrition impacts. It competes with similar offerings from Nestle and others in the enteral nutrition space, distinguished by its child-focused calorie density. Supply chains emphasize sterile production to meet regulatory standards across continents.

Adoption is strong in hospitals and home care, with validation from sources like pharmacy distributors confirming its role in diätmanagement. Regulations from bodies like the FDA and EMA ensure safety, focusing on allergen-free profiles suitable for sensitive young patients.

Market trends favor ready-to-drink formats for ease, positioning Frebini as a staple in pediatric protocols worldwide.

Fresenius Kabi develops and markets Frebini Energy Drink as part of its specialized nutrition portfolio. The company focuses on innovative solutions for clinical nutrition needs.

Issuer shares trade under ISIN DE0005785604. This provides background on the company behind the product.

Disclaimer: This article is not investment advice. Stocks are volatile financial instruments.